Table 2:

Risk factors and comorbidities for patients with TVD

ParameterTVD
P-value
OPCAB (n = 272)ONCABG (n = 155)
Hyperlipidaemia (%)76.975.50.79
Hypertension (%)48.261.30.01
Positive family History (%)37.234.90.47
Diabetes (%)25.720.60.28
Smoking (%)58.665.60.19
Adipositas (%)52.545.20.19
PAD (%)16.09.70.08
COPD (%)2.95.80.20
Acute MI (<90 days) (%)15.420.00.23
Previous MI (>90 days) (%)35.748.40.01
Cerebrovascular disease (%)1.80.00.16
Renal disease (%)0.71.90.62
ParameterTVD
P-value
OPCAB (n = 272)ONCABG (n = 155)
Hyperlipidaemia (%)76.975.50.79
Hypertension (%)48.261.30.01
Positive family History (%)37.234.90.47
Diabetes (%)25.720.60.28
Smoking (%)58.665.60.19
Adipositas (%)52.545.20.19
PAD (%)16.09.70.08
COPD (%)2.95.80.20
Acute MI (<90 days) (%)15.420.00.23
Previous MI (>90 days) (%)35.748.40.01
Cerebrovascular disease (%)1.80.00.16
Renal disease (%)0.71.90.62

PAD: peripheral artery disease; COPD: chronic obstructive pulmonary disease; MI: myocardial infarction.

Table 2:

Risk factors and comorbidities for patients with TVD

ParameterTVD
P-value
OPCAB (n = 272)ONCABG (n = 155)
Hyperlipidaemia (%)76.975.50.79
Hypertension (%)48.261.30.01
Positive family History (%)37.234.90.47
Diabetes (%)25.720.60.28
Smoking (%)58.665.60.19
Adipositas (%)52.545.20.19
PAD (%)16.09.70.08
COPD (%)2.95.80.20
Acute MI (<90 days) (%)15.420.00.23
Previous MI (>90 days) (%)35.748.40.01
Cerebrovascular disease (%)1.80.00.16
Renal disease (%)0.71.90.62
ParameterTVD
P-value
OPCAB (n = 272)ONCABG (n = 155)
Hyperlipidaemia (%)76.975.50.79
Hypertension (%)48.261.30.01
Positive family History (%)37.234.90.47
Diabetes (%)25.720.60.28
Smoking (%)58.665.60.19
Adipositas (%)52.545.20.19
PAD (%)16.09.70.08
COPD (%)2.95.80.20
Acute MI (<90 days) (%)15.420.00.23
Previous MI (>90 days) (%)35.748.40.01
Cerebrovascular disease (%)1.80.00.16
Renal disease (%)0.71.90.62

PAD: peripheral artery disease; COPD: chronic obstructive pulmonary disease; MI: myocardial infarction.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close